C-Reactive Protein Isoforms Differ in Their Effects on Thrombus Growth

被引:107
作者
Molins, Blanca [1 ,2 ]
Pena, Esther [1 ]
Vilahur, Gemma [1 ]
Mendieta, Carlos [2 ]
Slevin, Mark [1 ,3 ]
Badimon, Lina [1 ]
机构
[1] UAB, Hosp Santa Creu & St Pau, CSIC, ICCC,Cardiovasc Res Ctr, Barcelona 08025, Spain
[2] Univ Barcelona, Dept Priodont, Fac Odontol, Barcelona, Spain
[3] Manchester Metropolitan Univ, Sch Biol Chem & Hlth Sci, Manchester M15 6BH, Lancs, England
关键词
C-reactive protein; isoforms; thrombosis; platelets;
D O I
10.1161/ATVBAHA.108.174359
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective - We studied the impact of native (natCRP) and modified CRP (mCRP) isoforms on platelet adhesion and thrombus growth under arterial flow. Methods and Results - Blood was perfused over type I collagen at a wall shear rate of 1500 s(-1), and platelet deposition and thrombus growth were evaluated by confocal microscopy. natCRP and mCRP were either incubated with blood before perfusion experiments or immobilized in the collagen surface and exposed to flowing blood. mCRP significantly increased platelet adhesion and thrombus growth when directly incubated with blood and when immobilized on a collagen surface (P < 0.05). In contrast, natCRP did not exert any effect. Confocal immunohistochemistry revealed the presence of CRP on the surface of adhered platelets and within the thrombus and showed an upregulation of P-selectin and CD36 in effluent platelets preincubated with mCRP (P < 0.05). Flow cytometry analysis of agonist-induced platelet activation demonstrated that mCRP, but not natCRP, significantly increased platelet surface P-selectin (P < 0.05) without modifying CD63 and PAC-1. Conclusions - Our data indicate that whereas serum natCRP may not affect thrombus growth, mCRP displays a prothrombotic phenotype enhancing not only platelet deposition, but also thrombus growth under arterial flow conditions. (Arterioscler Thromb Vasc Biol. 2008; 28: 2239-2246.)
引用
收藏
页码:2239 / U186
页数:16
相关论文
共 34 条
  • [1] BADIMON L, 1992, CIRCULATION, V86, P74
  • [2] BADIMON L, 2004, CORONARY THROMBOSIS
  • [3] C-reactive protein and other inflammatory risk markers in acute coronary syndromes
    Blake, GJ
    Ridker, PM
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 41 (04) : 37S - 42S
  • [4] Inflammatory cytokines stimulated C-reactive protein production by human coronary artery smooth muscle cells
    Calabró, P
    Willerson, JT
    Yeh, ETH
    [J]. CIRCULATION, 2003, 108 (16) : 1930 - 1932
  • [5] C-reactive protein promotes monocyte-platelet aggregation: an additional link to the inflammatory-thrombotic intricacy
    Danenberg, Haim D.
    Kantak, Neelesh
    Grad, Etty
    Swaminathan, Rajesh V.
    Lotan, Chaim
    Edelman, Elazer R.
    [J]. EUROPEAN JOURNAL OF HAEMATOLOGY, 2007, 78 (03) : 246 - 252
  • [6] Increased thrombosis after arterial injury in human C-reactive protein - Transgenic mice
    Danenberg, HD
    Szalai, AJ
    Swaminathan, RV
    Peng, L
    Chen, ZP
    Seifert, P
    Fay, WP
    Simon, DI
    Edelman, ER
    [J]. CIRCULATION, 2003, 108 (05) : 512 - 515
  • [7] Immunohistochemical localization of modified C-reactive protein antigen in normal vascular tissue
    Diehl, EE
    Haines, GK
    Radosevich, JA
    Potempa, LA
    [J]. AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2000, 319 (02) : 79 - 83
  • [8] FIEDEL BA, 1976, J IMMUNOL, V117, P1073
  • [9] Ability of anti-glycoprotein IIb/IIIa agents to dissolve platelet thrombi formed on a collagen surface under blood flow conditions
    Goto, S
    Tamura, N
    Ishida, H
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 44 (02) : 316 - 323
  • [10] Activation of human platelets by misfolded proteins
    Herczenik, Eszter
    Bouma, Barend
    Korporaal, Suzanne J. A.
    Strangi, Remo
    Zeng, Qinghong
    Gros, Piet
    Van Eck, Miranda
    Van Berkel, Theo J. C.
    Gebbink, Martijn F. B. G.
    Akkerman, Jan-Willem N.
    [J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2007, 27 (07) : 1657 - 1665